Literature DB >> 25201384

Paediatric rheumatic disease: Diagnosing macrophage activation syndrome in systemic JIA.

Sebastiaan J Vastert1, Berent J Prakken1.   

Abstract

Macrophage activation syndrome (MAS) in systemic juvenile idiopathic arthritis (sJIA) is difficult to distinguish from active sJIA or sepsis. A collaborative effort scoring the performance of different clinical diagnostic criteria provides valuable guidance to clinicians, but challenges in the diagnosis of sJIA-related MAS remain.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25201384     DOI： 10.1038/nrrheum.2014.143

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  10 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

2.  Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.

Authors:  Masaki Shimizu; Tadafumi Yokoyama; Keiko Yamada; Hisashi Kaneda; Hideo Wada; Taizo Wada; Tomoko Toma; Kazuhide Ohta; Yoshihito Kasahara; Akihiro Yachie
Journal:  Rheumatology (Oxford)       Date:  2010-05-14       Impact factor: 7.580

Review 3.  Familial and acquired hemophagocytic lymphohistiocytosis.

Authors:  G E Janka
Journal:  Annu Rev Med       Date:  2012       Impact factor: 13.739

Review 4.  Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions.

Authors:  Elizabeth D Mellins; Claudia Macaubas; Alexei A Grom
Journal:  Nat Rev Rheumatol       Date:  2011-06-07       Impact factor: 20.543

5.  Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Authors:  Sergio Davì; Francesca Minoia; Angela Pistorio; AnnaCarin Horne; Alessandro Consolaro; Silvia Rosina; Francesca Bovis; Rolando Cimaz; Maria Luz Gamir; Norman T Ilowite; Isabelle Kone-Paut; Sheila Knupp Feitosa de Oliveira; Deborah McCurdy; Clovis Artur Silva; Flavio Sztajnbok; Elena Tsitsami; Erbil Unsal; Jennifer E Weiss; Nico Wulffraat; Mario Abinun; Amita Aggarwal; Maria Teresa Apaz; Itziar Astigarraga; Fabrizia Corona; Ruben Cuttica; Gianfranco D'Angelo; Eli M Eisenstein; Soad Hashad; Loredana Lepore; Velma Mulaosmanovic; Susan Nielsen; Sampath Prahalad; Donato Rigante; Valda Stanevicha; Gary Sterba; Gordana Susic; Syuji Takei; Ralf Trauzeddel; Mabruka Zletni; Nicolino Ruperto; Alberto Martini; Randy Q Cron; Angelo Ravelli
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

6.  The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.

Authors:  Jack Bleesing; Anne Prada; David M Siegel; Joyce Villanueva; Judyann Olson; Norman T Ilowite; Hermine I Brunner; Thomas Griffin; Thomas B Graham; David D Sherry; Murray H Passo; Athimalaipet V Ramanan; Alexandra Filipovich; Alexei A Grom
Journal:  Arthritis Rheum       Date:  2007-03

Review 7.  Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Silvia Magni-Manzoni; Angela Pistorio; Cristina Besana; Tiziana Foti; Nicolino Ruperto; Stefania Viola; Alberto Martini
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406

8.  Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Authors:  Mark Gorelik; Ndate Fall; Mekibib Altaye; Michael G Barnes; Susan D Thompson; Alexei A Grom; Raphael Hirsch
Journal:  J Rheumatol       Date:  2013-05-15       Impact factor: 4.666

9.  Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis.

Authors:  Wilco de Jager; Sebastiaan J Vastert; Jeffrey M Beekman; Nico M Wulffraat; Wietse Kuis; Paul J Coffer; Berent J Prakken
Journal:  Arthritis Rheum       Date:  2009-09

10.  The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis.

Authors:  Michael Frosch; Martina Ahlmann; Thomas Vogl; Helmut Wittkowski; Nico Wulffraat; Dirk Foell; Johannes Roth
Journal:  Arthritis Rheum       Date:  2009-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.